Researchers identify target protein to weaken glioblastoma brain cancer cells

The short version

• Ohio State University researchers found that targeting the protein SET can weaken defenses in glioblastoma brain cancer cells.[ScienceDaily]
• The method works by restoring the activity of PP2A, an enzyme that glioblastoma cells naturally suppress using SET and related proteins.[ScienceDaily]
• Laboratory and preclinical models showed tumor formation was prevented when SET was suppressed.[ScienceDaily]
• Findings are strictly preliminary, requiring formal human clinical trials to verify whether the therapeutic approach is safe and effective.[ScienceDaily]

Key facts

• Ohio State University researchers discovered that targeting the protein SET may make glioblastoma cells easier to treat.[ScienceDaily]
• Blocking the SET protein prevented tumor development in preclinical laboratory models.[ScienceDaily]
• The mechanism restores the activity of PP2A, a tumor-suppressing enzyme hindered by glioblastoma cells.[ScienceDaily]
• Researchers evaluated an FDA-approved antipsychotic drug that boosts PP2A activity, though it is not approved for glioblastoma treatment outside clinical trials.[ScienceDaily]

Sources

Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.

• Scientists find a weak spot in one of the deadliest brain cancersScienceDaily - Science